Trial Profile
A Phase I/II Study of Interferon-Beta Gene Transfer (Ad.hIFN-β) in the Treatment of Refractory Colorectal Carcinoma With Liver Metastases
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon-beta gene therapy (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 07 Dec 2007 Status change from in progress to completed
- 07 Sep 2006 Status change
- 31 Aug 2006 Status change